title: Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance.
abstract: DNA fragments released from cancer cells into the blood can be used to generate molecular profiles of tumors. Non-invasive 'liquid biopsies' can be used to monitor minimal residual disease and detect the emergence of drug resistance.
authors.forename: Giulia
authors.initials: G
authors.lastname: Siravegna
authors.forename: Alberto
authors.initials: A
authors.lastname: Bardelli
mesh_terms: D002474:Cell-Free System; D004273:DNA, Neoplasm / Q000032:analysis*; D019008:Drug Resistance, Neoplasm; D005838:Genotype; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis*; D009369:Neoplasms / Q000097:blood* / Q000235:genetics* / Q000473:pathology
chemical_list: D004273:DNA, Neoplasm